Elanix Biotechnologies AG announces cash capital increase with indirect subscription rights from currently EUR 7,779,139 by up to EUR 777,910 to up to EUR 8,557,049
. – Subscription period for current shareholders from July 27 to August 10, 2018 – Subscription price for shareholders to be EUR 2.75 – Management explaining planned usage of capital raised and future milestones Elanix Biotechnologies AG ("Elanix"; "Company"), a Mehr